Obesity, Appetite Control & Diabetes
Obesity, Appetite Control & Diabetes(肥胖，食欲控制 & 糖尿病)
Obesity, Appetite Control & Diabetes
Satiety, appetite, and craving are CNS drives, whereas metabolism and energy utilization are peripheral endocrine actions.
Stephen M. Stahl, M.D., Ph.D. read more
Obesity, Appetite Control & Diabetes 相关产品(350)
- GC41406AMP-DeoxynojirimycinCAS: 216758-20-2纯度: >95.00%
Inhibitor of glucosylceramide synthase and non-lysosomal glucosylceramidase
- GC41743[Des-His1,Glu9]-Glucagon (1-29) amide (trifluoroacetate salt)纯度: >95.00%
A peptide glucagon receptor antagonist
- GC4190713C C16 Sphingomyelin (d18:1/16:0)CAS: 144236-99-7纯度: >98.00%
An internal standard for the quantification of C16 sphingomyelin
- GC422913-Hydroxyisobutyrate (sodium salt)CAS: 1219589-99-7纯度: >95.00% / >96.00%
An intermediate in the metabolism of valine
- GC424344-methyl-2-Oxovalerate (sodium salt)CAS: 4502-00-5纯度: >95.00%
A metabolite of leucine catabolism
- GC426208-Aminopyrene-1,3,6-trisulfonic Acid (sodium salt)CAS: 196504-57-1纯度: >95.00%
An anionic fluorescent dye
- GC426559-PAHSA 13C4CAS: 2748638-71-1纯度: >95.00%
An internal standard for the quantification of 9-PAHSA
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC41406 | AMP-Deoxynojirimycin | 216758-20-2 | >95.00% | |
Inhibitor of glucosylceramide synthase and non-lysosomal glucosylceramidase | ||||
| GC41601 | CAY10591 | 839699-72-8 | >98.00% | |
A SIRT1 activator | ||||
| GC41647 | Pinolenic Acid | 16833-54-8 | >98.00% | |
A polyunsaturated fatty acid | ||||
| GC41699 | (Des-octanoyl)-Ghrelin (human) (trifluoroacetate salt) | - | >95.00% | |
A peptide hormone | ||||
| GC41743 | [Des-His1,Glu9]-Glucagon (1-29) amide (trifluoroacetate salt) | - | >95.00% | |
A peptide glucagon receptor antagonist | ||||
| GC41746 | [Ser4,Ile8]-Oxytocin (trifluoroacetate salt) | - | >95.00% | |
A neuropeptide | ||||
| GC41777 | 1,2,3-Tripalmitoleoyl-rac-glycerol | 20246-55-3 | >98.00% | |
A triacylglycerol | ||||
| GC41794 | 1,2-Diheptanoyl-sn-glycero-3-PC | 39036-04-9 | >95.00% | |
A synthetic phosphatidylcholine | ||||
| GC41869 | 10-OAHSA | 2005487-34-1 | >95.00% | |
A FAHFA with anti-diabetic potential | ||||
| GC41871 | 10-POHSA | - | >95.00% | |
A FAHFA with anti-diabetic potential | ||||
| GC41872 | 10-SAHSA | 2320261-81-0 | >95.00% | |
A FAHFA with anti-diabetic potential | ||||
| GC41873 | 10-Thiastearic Acid | 105099-89-6 | >98.00% | |
A stearoyl CoA desaturase inhibitor | ||||
| GC41907 | 13C C16 Sphingomyelin (d18:1/16:0) | 144236-99-7 | >98.00% | |
An internal standard for the quantification of C16 sphingomyelin | ||||
| GC42035 | 1-Palmitoyl-2-Stearoyl-3-Oleoyl-rac-glycerol | 2190-28-5 | >98.00% | |
A triacylglycerol | ||||
| GC42291 | 3-Hydroxyisobutyrate (sodium salt) | 1219589-99-7 | >95.00% / >96.00% | |
An intermediate in the metabolism of valine | ||||
| GC42411 | 4-hydroxy Nonenal Alkyne | 1011268-23-7 | >98.00% | |
4-HNE modified for click chemistry | ||||
| GC42434 | 4-methyl-2-Oxovalerate (sodium salt) | 4502-00-5 | >95.00% | |
A metabolite of leucine catabolism | ||||
| GC42548 | 5-hydroxy Saxagliptin (hydrochloride) | - | >95.00% | |
A major active metabolite of saxagliptin | ||||
| GC42620 | 8-Aminopyrene-1,3,6-trisulfonic Acid (sodium salt) | 196504-57-1 | >95.00% | |
An anionic fluorescent dye | ||||
| GC42655 | 9-PAHSA 13C4 | 2748638-71-1 | >95.00% | |
An internal standard for the quantification of 9-PAHSA | ||||
| GC42674 | ABD459 | 1047670-51-8 | >95.00% | |
A neutral CB1 antagonist | ||||
| GC42786 | Aminoacetone (hydrochloride) | 7737-17-9 | >98.00% | |
A catabolite of threonine and glycine | ||||
| GC42791 | Amorfrutin B | 78916-42-4 | >97.00% | |
A PPARγ agonist | ||||
| GC42795 | Amylin (human) (amidated) (trifluoroacetate salt) | - | >95.00% | |
A peptide hormone | ||||